|
A recent change in TRICARE policy now allows you to more accurately file claims for the home infusion medications you prescribe to your patients.
The new procedure requires you to include the National Drug Code (NDC) number in addition to the J-code when filing claims for home infusion medications. The J-code, from the Level II Healthcare Common Procedure Coding System (HCPCS), specifies the name and the dose of the prescribed injectable drug.
The new policy went into effect July 1, 2006, but is retroactive for claims filed since April 1, 2005, which allows you to re-file claims from that date on and may result in a larger payment.
“Providers will now put the J-code on the form and, in the same block, they would have put the NDC number. That’s the new part,” said Miller Brown, a systems engineer in Humana Military’s Claims Oversight Department.
“Because there are a lot of different manufacturers, and they have their own prices, with the NDC number it tells specifically what drug is being prescribed and the units associated with that number,” Brown said.
Home infusion medications include: antibiotics for post-op infections or osteomylitis, etc.; Cerezyme for Gaucher Disease; Flolan for patients awaiting lung transplants; and Factor VIII for hemophilia.
If you’re one of the many providers enjoying the benefits of electronic claims filing, the following instructions give you the loops or segments where you should send J-codes and NDC numbers in the HIPAA-standard ASC X12 837 electronic claims format:
|